Author: rachael
-
First Ever Peer-Reviewed Expert Consensus on the Use of Ketogenic Therapy for Serious Mental Illness
Baszucki Group today announced the publication of the first evidence-based expert consensus on the safe and effective implementation of ketogenic therapy for serious mental illness. This Delphi consensus, funded by Baszucki Group and led by Dr. Georgia Ede, provides clinicians with clearer guidance on how metabolic approaches like ketogenic metabolic therapy can be thoughtfully integrated into individualized psychiatric treatment plans alongside existing first-line treatments and within multidisciplinary care teams.
-
Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
Baszucki Group today announced an expanded commitment to the landmark Cleveland Clinic Brain Study. Launched in 2022, this ambitious longitudinal study plans to follow healthy individuals over a 20-year period with the goal of identifying early disease markers and therapeutic targets needed to prevent and ultimately cure neurological diseases. The commitment from Baszucki Group brings their total donation to the study to $450,000.